S&P 500   3,946.53 (+0.24%)
DOW   32,053.41 (+0.07%)
QQQ   310.77 (+1.52%)
AAPL   159.61 (+1.13%)
MSFT   278.79 (+2.39%)
META   205.57 (+2.88%)
GOOGL   105.69 (+2.24%)
AMZN   99.17 (+0.48%)
TSLA   192.33 (+0.62%)
NVDA   270.25 (+2.10%)
NIO   9.27 (+1.98%)
BABA   86.18 (+3.02%)
AMD   100.57 (+3.06%)
T   18.52 (+0.71%)
F   11.49 (+0.09%)
MU   61.26 (+5.31%)
CGC   1.91 (+1.60%)
GE   91.52 (+2.15%)
DIS   96.33 (+1.51%)
AMC   4.42 (+1.84%)
PFE   40.27 (+0.65%)
PYPL   72.71 (-2.19%)
NFLX   316.35 (+7.64%)
S&P 500   3,946.53 (+0.24%)
DOW   32,053.41 (+0.07%)
QQQ   310.77 (+1.52%)
AAPL   159.61 (+1.13%)
MSFT   278.79 (+2.39%)
META   205.57 (+2.88%)
GOOGL   105.69 (+2.24%)
AMZN   99.17 (+0.48%)
TSLA   192.33 (+0.62%)
NVDA   270.25 (+2.10%)
NIO   9.27 (+1.98%)
BABA   86.18 (+3.02%)
AMD   100.57 (+3.06%)
T   18.52 (+0.71%)
F   11.49 (+0.09%)
MU   61.26 (+5.31%)
CGC   1.91 (+1.60%)
GE   91.52 (+2.15%)
DIS   96.33 (+1.51%)
AMC   4.42 (+1.84%)
PFE   40.27 (+0.65%)
PYPL   72.71 (-2.19%)
NFLX   316.35 (+7.64%)
S&P 500   3,946.53 (+0.24%)
DOW   32,053.41 (+0.07%)
QQQ   310.77 (+1.52%)
AAPL   159.61 (+1.13%)
MSFT   278.79 (+2.39%)
META   205.57 (+2.88%)
GOOGL   105.69 (+2.24%)
AMZN   99.17 (+0.48%)
TSLA   192.33 (+0.62%)
NVDA   270.25 (+2.10%)
NIO   9.27 (+1.98%)
BABA   86.18 (+3.02%)
AMD   100.57 (+3.06%)
T   18.52 (+0.71%)
F   11.49 (+0.09%)
MU   61.26 (+5.31%)
CGC   1.91 (+1.60%)
GE   91.52 (+2.15%)
DIS   96.33 (+1.51%)
AMC   4.42 (+1.84%)
PFE   40.27 (+0.65%)
PYPL   72.71 (-2.19%)
NFLX   316.35 (+7.64%)
S&P 500   3,946.53 (+0.24%)
DOW   32,053.41 (+0.07%)
QQQ   310.77 (+1.52%)
AAPL   159.61 (+1.13%)
MSFT   278.79 (+2.39%)
META   205.57 (+2.88%)
GOOGL   105.69 (+2.24%)
AMZN   99.17 (+0.48%)
TSLA   192.33 (+0.62%)
NVDA   270.25 (+2.10%)
NIO   9.27 (+1.98%)
BABA   86.18 (+3.02%)
AMD   100.57 (+3.06%)
T   18.52 (+0.71%)
F   11.49 (+0.09%)
MU   61.26 (+5.31%)
CGC   1.91 (+1.60%)
GE   91.52 (+2.15%)
DIS   96.33 (+1.51%)
AMC   4.42 (+1.84%)
PFE   40.27 (+0.65%)
PYPL   72.71 (-2.19%)
NFLX   316.35 (+7.64%)
NASDAQ:CLVS

Clovis Oncology - CLVS Earnings Date, Estimates & Call Transcripts

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
$0.08
$0.10
50-Day Range
$0.08
$1.09
52-Week Range
$0.08
$3.32
Volume
1.16 million shs
Average Volume
8.88 million shs
Market Capitalization
$11.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Skip Charts & View Estimated and Actual Earnings Data

CLVS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CLVS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Clovis Oncology Analyst Forecasts

Current Year EPS Consensus Estimate: $-1.68 EPS
Next Year EPS Consensus Estimate: $-0.98 EPS

Clovis Oncology Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/9/2022Q3 2022($0.42)($0.39)+$0.03($0.39)$34.79 million$30.66 million
8/8/2022Q2 2022($0.42)($0.43)($0.01)($0.36)$37.82 million$32.14 million    
5/4/2022Q1 2022($0.43)($0.44)($0.01)($0.44)$37.03 million$34.25 million    
2/23/2022Q4 2021($0.60)($0.49)+$0.11($0.48)$39.30 million$35.97 million    
11/3/20219/30/2021($0.48)($0.56)($0.08)($0.56)$38.73 million$37.92 million    
8/4/20216/30/2021($0.57)($0.61)($0.04)($0.61)$40.81 million$36.82 million    
5/5/20213/31/2021($0.72)($0.64)+$0.08($0.64)$44.84 million$38.05 million  
2/22/202112/31/2020($0.76)($1.02)($0.26)($0.46)$43.16 million$43.30 million  
11/5/20209/30/2020($1.01)($0.89)+$0.12($0.89)$42.34 million$38.77 million  
8/6/20206/30/2020($1.04)($1.15)($0.11)($1.07)$44.65 million$39.89 million  
5/5/20203/31/2020($1.28)($1.28)($1.17)$41.80 million$42.56 million  
2/24/2020Q4 2019($1.71)($1.81)($0.10)($1.81)$38.79 million$39.31 million  
11/7/2019Q3($1.89)($1.72)+$0.17($2.06)$35.84 million$37.60 million  
8/1/2019Q2 2019($1.70)($2.27)($0.57)($2.27)$34.92 million$32.98 million
5/7/20193/31/2019($1.80)($1.63)+$0.17($1.63)$32.10 million$33.12 million
2/26/2019Q4 2018($1.68)($1.88)($0.20)($1.88)$30.46 million$30.40 million  
10/30/20189/30/2018($1.60)($1.71)($0.11)($1.71)$30.11 million$22.76 million
8/1/2018Q2 2018($1.38)($1.94)($0.56)($1.94)$22.44 million$23.76 million
5/8/2018Q1 2018($1.36)($1.54)($0.18)($1.54)$18.34 million$18.50 million
2/26/2018Q4 2017($1.29)($1.04)+$0.25($1.50)$19.42 million$17.04 million  
11/1/2017Q3 2017($1.18)($1.24)($0.06)($1.24)$21.12 million$16.81 million
8/2/2017Q2 2017($1.27)($1.29)($0.02)$1.30$13.07 million$14.62 million  
5/3/2017Q1 2017($1.43)($1.33)+$0.10($1.33)$6.04 million$7.05 million  
2/22/2017Q416($1.65)($1.83)($0.18)($1.83)$0.08 million  
11/3/2016Q316($1.95)($1.70)+$0.25($1.70)  
8/8/2016Q216($2.13)($2.07)+$0.06($0.77)  
5/5/2016Q116($2.39)($2.17)+$0.22($2.17)  
2/25/2016Q415($2.39)($2.23)+$0.16($1.34)  
11/5/2015Q315($2.07)($2.62)($0.55)($2.62)  
8/6/2015Q215($2.11)($2.10)+$0.01($2.10)$1.17 million  
5/6/2015Q115($1.78)($1.86)($0.08)($1.86)$13.60 million  
2/25/2015Q414($1.41)($1.62)($0.21)($1.62)  
11/6/2014Q314($1.03)($1.17)($0.14)($1.17)  
8/7/2014Q214($0.93)($1.03)($0.10)($1.03)$13.60 million  
5/8/2014Q114($0.85)($0.91)($0.06)($0.91)$13.60 million  
2/27/2014Q4 2013($0.75)($0.92)($0.17)($0.92)  
10/31/2013Q3 2013($0.63)($0.68)($0.05)($0.68)  
8/1/2013Q2 2013($0.69)($0.72)($0.03)($0.72)  
5/7/2013Q1 2013($0.60)($0.60)($0.60)  
2/28/2013Q4 2012($0.76)($0.81)($0.05)($0.81)
11/5/2012Q3 2012($0.68)($0.71)($0.03)($0.71)
8/8/2012Q2 2012($0.61)($0.61)($0.61)
5/8/2012Q1 2012($0.81)($0.74)+$0.07($0.62)
3/7/2012Q4 2011($0.79)($1.30)($0.51)($1.30)












Clovis Oncology Earnings - Frequently Asked Questions

How much revenue does Clovis Oncology generate each year?

Clovis Oncology (NASDAQ:CLVS) has a recorded annual revenue of $148.76 million.

How much profit does Clovis Oncology generate each year?

Clovis Oncology (NASDAQ:CLVS) has a recorded net income of -$264.52 million. CLVS has generated -$1.83 earnings per share over the last four quarters.

What is Clovis Oncology's EPS forecast for next year?

Clovis Oncology's earnings are expected to grow from ($1.68) per share to ($0.98) per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:CLVS) was last updated on 3/23/2023 by MarketBeat.com Staff